AGL 38.50 Increased By ▲ 0.93 (2.48%)
AIRLINK 132.00 Decreased By ▼ -0.50 (-0.38%)
BOP 5.60 Decreased By ▼ -0.04 (-0.71%)
CNERGY 3.84 Increased By ▲ 0.07 (1.86%)
DCL 8.67 Decreased By ▼ -0.20 (-2.25%)
DFML 40.80 Decreased By ▼ -0.20 (-0.49%)
DGKC 88.71 Decreased By ▼ -1.45 (-1.61%)
FCCL 35.20 Increased By ▲ 0.12 (0.34%)
FFBL 66.49 Decreased By ▼ -0.01 (-0.02%)
FFL 10.47 Increased By ▲ 0.32 (3.15%)
HUBC 109.50 Increased By ▲ 3.10 (2.91%)
HUMNL 14.66 Increased By ▲ 1.26 (9.4%)
KEL 4.81 Decreased By ▼ -0.05 (-1.03%)
KOSM 7.07 Increased By ▲ 0.22 (3.21%)
MLCF 42.50 Increased By ▲ 0.70 (1.67%)
NBP 59.47 Increased By ▲ 0.89 (1.52%)
OGDC 184.00 Increased By ▲ 2.75 (1.52%)
PAEL 25.60 Decreased By ▼ -0.10 (-0.39%)
PIBTL 5.90 Increased By ▲ 0.07 (1.2%)
PPL 147.50 Decreased By ▼ -0.90 (-0.61%)
PRL 23.51 Increased By ▲ 0.29 (1.25%)
PTC 16.45 Increased By ▲ 1.21 (7.94%)
SEARL 69.28 Increased By ▲ 0.49 (0.71%)
TELE 7.25 Increased By ▲ 0.01 (0.14%)
TOMCL 35.80 Decreased By ▼ -0.20 (-0.56%)
TPLP 7.55 Increased By ▲ 0.15 (2.03%)
TREET 14.19 Decreased By ▼ -0.05 (-0.35%)
TRG 50.80 Decreased By ▼ -0.05 (-0.1%)
UNITY 26.83 Increased By ▲ 0.43 (1.63%)
WTL 1.22 Increased By ▲ 0.01 (0.83%)
BR100 9,820 Increased By 52.7 (0.54%)
BR30 29,792 Increased By 391.6 (1.33%)
KSE100 92,373 Increased By 435.5 (0.47%)
KSE30 28,829 Increased By 85.3 (0.3%)
Pakistan

Pakistan to produce three million CanSino doses every month

  • SAPM says the product, PakVac, has passed rigorous internal QA testing, an important step to help in our vaccine supply line
  • The vaccine would be available for administration to the citizens by the end of May after approval from the Drug Regulatory Authority of Pakistan
Published May 25, 2021

(Karachi) Pakistan will produce three million doses of China's single-dose CanSino vaccine every month at the National Institute of Health (NIH) vaccination plant, Arab News Pakistan reported this quoting the government.

The move will reduce the country's dependency on importing vaccines from other countries.

Earlier, Pakistan successfully produced CanSino COVID-19 vaccine in a bid to speed up its immunization drive.

In a tweet, Special Assistant to Prime Minister on National Health Services, Regulations & Coordination Faisal Sultan said: "Congratulations to the NIH Pak team and its leadership for successful fill/finish (from concentrate) of the Cansino vaccine with the help of Cansino Bio Inc. China."

He added, "The product has passed rigorous internal QA testing. An imp step to help in our vaccine supply line."

The vaccine, named PakVac, would be available for administration to the citizens by the end of May after approval from the Drug Regulatory Authority of Pakistan (DRAP). The trial test of the vaccine was held at the National Institute of Health's (NIH) Quality Control Unit.

Earlier, the government decided that it will locally produce the CanSino COVID-19 vaccine with the help of China.

NIH Head Maj. Gen. Aamer Ikram told the parliament's health committee that China's single-dose CanSinoBio vaccine will be prepared locally.

He said Beijing agreed to transfer the technology for the vaccine to Islamabad while a Chinese team is overseeing the project at the NIH.

Comments

Comments are closed.